Loading...
Market
Type of SmarterDx's next major funding round by 2025
5
Resolution / Starting Odds
Series C • 33%
Debt Financing • 33%
Acquisition • 34%
Official announcements from SmarterDx or credible financial news sources
Story
SmarterDx Secures $50 Million Series B Funding, Total Funding Reaches $71 Million
May 14, 2024, 02:22 PM
SmarterDx, an AI startup specializing in clinical review and quality audits for medical claims, has closed a $50 million Series B funding round. This funding round was led by Transform Capital, with continued support from Bessemer Venture Partners, Flare Capital, Floodgate Fund, and Virtue VC. The new investment brings SmarterDx's total funding to $71 million. The company's growth trajectory has been remarkable, with a previous $5 million Seed round in 2022. SmarterDx's clinical AI is designed to increase hospital revenues through improved clinical documentation integrity (CDI) and quality reporting.
View original story
Similar markets
Venture Capital • 33%
Public Stock Offering • 33%
Private Equity • 33%
Series B • 33%
Series C • 33%
No new major funding • 33%
Series C • 33%
Acquisition • 33%
No further rounds • 34%
Series B • 33%
Series C • 33%
No additional funding • 33%
Less than $10M • 25%
$10M to $20M • 25%
$20M to $50M • 25%
More than $50M • 25%
SkyLake • 25%
SoftBank • 25%
Sequoia Capital • 25%
New Unnamed Investor • 25%
